Adaptimmune stock plunges after announcing Nasdaq delisting plans
James W. Noyce, a director of West Bancorporation, Inc. (NASDAQ:WTBA), has informed the company that he will not stand for re-election at the company’s annual meeting of shareholders scheduled for April 2026. According to a statement released in a regulatory filing, Mr. Noyce will continue to serve as a director until the 2026 annual meeting.
Mr. Noyce, age 70, also stated he will not seek re-election to the board of directors of West Bank. He has served as a director of West Bancorporation for 17 years, including roles on the nominating and governance committee and as chair of the audit committee. He previously served as the company’s chair for six years.
The company said Mr. Noyce’s decision was not due to any disagreement with West Bancorporation regarding its operations, policies, or practices.
This information is based on a statement issued in a filing with the Securities and Exchange Commission.
In other recent news, West Bancorporation reported its second-quarter earnings for 2025, surpassing analyst expectations. The company achieved an earnings per share (EPS) of $0.47, slightly above the forecasted $0.46. Additionally, West Bancorporation’s revenue reached $23.83 million, exceeding the projected $23.75 million. These results indicate a positive performance for the quarter, despite broader market uncertainties. Analysts had anticipated slightly lower figures, making the actual results noteworthy for investors. The company’s financial performance highlights its ability to exceed market expectations in both earnings and revenue. These developments are crucial for stakeholders monitoring West Bancorporation’s progress.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.